Your session is about to expire
← Back to Search
Other
Cranberry and Quillaja for Uncomplicated Urinary Tract Infection
Phase 2
Waitlist Available
Led By Blayne Welk, MD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights
Study Summary
This trialwill look at how cranberry and quillaja capsules can help treat urinary tract infections.
Eligible Conditions
- Urinary Tract Infection
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to UTI antibiotic initiation
Urinary Tract Infection Symptoms Assessment Questionnaire (UTISA)
Secondary outcome measures
Microbiome changes prior to and post antibiotic initiation
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cranberry and QuillajaExperimental Treatment1 Intervention
one 450mg cranberry capsule and one 50mg quillaja capsule in the morning and evening for 14 days.
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
656 Previous Clinical Trials
413,426 Total Patients Enrolled
3 Trials studying Urinary Tract Infection
342 Patients Enrolled for Urinary Tract Infection
Urobiome TherapeuticsUNKNOWN
St. Joseph's Health Care LondonOTHER
27 Previous Clinical Trials
2,496 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your weight is within a certain range based on your height.You have reported abnormalities in your urinary tract.You have a history of serious heart problems, as determined by the doctor.You have a history of serious liver disease, as determined by the doctor.You have a history of serious stomach or intestinal problems, as determined by the doctor.You have been regularly using products containing Vaccinium within 28 days before the start of the study.You are allergic to cranberry, tree bark, or quillaja.You have had a kidney infection or reflux in the past.You have a tube in your bladder to help you pee.You have a weakened immune system or are taking medication that weakens your immune system.Your in-office urine test shows signs of infection.You have a history of metabolic disorder or diabetes.You have a history of not fully emptying your bladder.You have had more than 5 urinary tract infections in the last 6 months, confirmed by either your own report or by a healthcare professional.You have taken antibiotics for a urinary tract infection in the past 28 days before the start of the study.Women under 18 years old who have symptoms of a simple urinary tract infection (UTI) before menopause.
Research Study Groups:
This trial has the following groups:- Group 1: Cranberry and Quillaja
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger